Skip to main content

Animations

MJFF Publications

6731 - 6740 of 8808 Results
Title
Year
  • Year
  • 2025
  • 2018
  • 2011
  • 2019
  • 2023
  • 2025
  • 2012
  • 2022
  • 2023
  • 2019
  • Summary Details
    RESTRICTED
    Title: Impact of inpatient mobility on outcomes in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107834
    Citation Count: 0
  • Summary Details
    OPEN
    Title: PINK1 Phosphorylates MIC60/Mitofilin to Control Structural Plasticity of Mitochondrial Crista Junctions
    Journal Name: Molecular Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.molcel.2018.01.026
    Citation Count: 100
  • Summary Details
    OPEN
    Title: Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2011.01.024
    Citation Count: 169
  • Summary Details
    RESTRICTED
    Title: Patient-Centered Clinical Trial Design: A Case Study in Parkinson’s Disease (P2.8-008)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p2.8-008
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: The Hypoxia Response Pathway: A Potential Intervention Target in Parkinson's Disease?
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.29688
    Citation Count: 8
  • Summary Details
    RESTRICTED
    Title: Combined assessment of blood glucocerebrosidase activity and α-synuclein levels in GBA1 mutation carriers: A novel potential biomarker
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107854
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: The meaning of a “hippo” response on the Montreal Cognitive Assessment in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2012.09.005
    Citation Count: 1
  • Summary Details
    RESTRICTED
    Title: Soluble urokinase-type plasminogen activator receptor (suPAR) is elevated in caregivers of patients with parkinsonism
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.019
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Is REM Sleep Behavior Disorder Changing? Secular Changes Versus Referral Patterns
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/mdc3.13842
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Generation of human midbrain organoids from induced pluripotent stem cells
    Journal Name: MNI Open Research
    Publisher: F1000 Research Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.12688/mniopenres.12816.1
    Citation Count: 12
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.